In vivo reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling

Abstract

Amphiregulin (AREG)−/− mice demonstrate impaired mammary development and form only rudimentary ductal epithelial trees; however, AREG −/− glands are still capable of undergoing alveologenesis and lactogenesis during pregnancy. Transplantation of AREG −/− mammary epithelial cells into cleared mouse mammary fat pads results in a diminished capacity for epithelial growth (∼15%) as compared to that of wild-type mammary epithelial cells. To determine whether estrogen receptor α (ERα, also known as ESR1) and/or AREG signaling were necessary for non-mammary cell redirection, we inoculated either ERα −/− or AREG −/− mammary cells with nonmammary progenitor cells (WAP-Cre/Rosa26LacZ+ male testicular cells or GFP-positive embryonic neuronal stem cells). ERα −/− cells possessed a limited ability to grow or reprogram non-mammary cells in transplanted mammary fat pads. AREG −/− mammary cells were capable of redirecting both types of non-mammary cell populations to mammary phenotypes in regenerating mammary outgrowths. Transplantation of fragments from AREG-reprogrammed chimeric outgrowths resulted in secondary outgrowths in six out of ten fat pads, demonstrating the self-renewing capacity of the redirected nonmammary cells to contribute new progeny to chimeric outgrowths. Nestin was detected at the leading edges of developing alveoli, suggesting that its expression may be essential for lobular expansion.

<p>Current and emerging biomarkers of frailty in the elderly</p>

“…Systemic infusion studies have shown that MSCs have limited capacity to cross the endothelial barrier, with poor migration to uninjured skeletal tissue. This is in contrast to COP cells,97 which are fluid-phase, allowing them to cross the endothelial barrier 98…”

A 3D bioprinter platform for mechanistic analysis of tumoroids and chimeric mammary organoids

“…Understanding the capacity of the local microenvironment (niche) to control the fate of cells is of vital importance to developmental biology, cancer biology, and regenerative medicine 1–4 . To this end, our group and colleagues have previously demonstrated that the regenerating mouse mammary gland can direct stem cells of non-mammary origin to a mammary epithelial cell fate in vivo 1,5–15 . The capacity of the local microenvironment to control differentiation extends to cancer cells as well 6,10,15,16 .…”